A detailed history of Profund Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 44,872 shares of ABBV stock, worth $8 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
44,872
Previous 47,004 4.54%
Holding current value
$8 Million
Previous $8.06 Million 9.91%
% of portfolio
0.34%
Previous 0.3%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $349,306 - $424,971
-2,132 Reduced 4.54%
44,872 $8.86 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $1.8 Million - $2.1 Million
11,603 Added 32.78%
47,004 $8.06 Million
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $487,770 - $555,769
-3,052 Reduced 7.94%
35,401 $6.45 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $179,430 - $202,080
1,304 Added 3.51%
38,453 $5.96 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $218,954 - $253,471
-1,639 Reduced 4.23%
37,149 $5.54 Million
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $400,312 - $498,162
3,021 Added 8.45%
38,788 $5.23 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $24.8 Million - $28.6 Million
-171,534 Reduced 82.75%
35,767 $5.7 Million
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $580,487 - $696,156
4,197 Added 2.07%
207,301 $33.5 Million
Q3 2022

Nov 04, 2022

SELL
$134.21 - $153.93 $1.18 Million - $1.35 Million
-8,788 Reduced 4.15%
203,104 $27.3 Million
Q2 2022

Aug 01, 2022

SELL
$137.62 - $174.96 $3.05 Million - $3.88 Million
-22,171 Reduced 9.47%
211,892 $32.5 Million
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $3.14 Million - $3.9 Million
-23,828 Reduced 9.24%
234,063 $37.9 Million
Q4 2021

Feb 08, 2022

SELL
$107.43 - $135.93 $4.57 Million - $5.78 Million
-42,503 Reduced 14.15%
257,891 $34.9 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $1.56 Million - $1.77 Million
-14,680 Reduced 4.66%
300,394 $32.4 Million
Q2 2021

Aug 12, 2021

SELL
$105.21 - $117.21 $917,641 - $1.02 Million
-8,722 Reduced 2.69%
315,074 $35.5 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $5.3 Million - $5.83 Million
-51,810 Reduced 13.79%
323,796 $35 Million
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $2.57 Million - $3.47 Million
31,902 Added 9.28%
375,606 $40.2 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $5.45 Million - $6.4 Million
-63,425 Reduced 15.58%
343,704 $30.1 Million
Q2 2020

Aug 03, 2020

BUY
$73.37 - $98.18 $8.5 Million - $11.4 Million
115,822 Added 39.76%
407,129 $40 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $6.85 Million - $10.4 Million
-106,197 Reduced 26.72%
291,307 $22.2 Million
Q4 2019

Feb 18, 2020

BUY
$72.13 - $90.25 $2.92 Million - $3.65 Million
40,453 Added 11.33%
397,504 $35.2 Million
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $1.65 Million - $1.99 Million
-26,220 Reduced 6.84%
357,051 $27 Million
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $2.85 Million - $3.64 Million
-43,333 Reduced 10.16%
383,271 $27.9 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $36,255 - $42,671
-470 Reduced 0.11%
426,604 $34.4 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $8.89 Million - $11 Million
-114,171 Reduced 21.09%
427,074 $39.4 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $4.31 Million - $4.79 Million
48,424 Added 9.83%
541,245 $51.2 Million
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $5.51 Million - $6.52 Million
-61,365 Reduced 11.07%
492,821 $45.7 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $5.01 Million - $6.71 Million
-54,429 Reduced 8.94%
554,186 $52.5 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $6.59 Million - $7.23 Million
-73,623 Reduced 10.79%
608,615 $58.9 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $3.66 Million - $4.67 Million
52,391 Added 8.32%
682,238 $60.6 Million
Q2 2017

Aug 11, 2017

BUY
N/A
629,847
629,847 $45.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.